Improved detection of synthetic lethal interactions in Drosophila cells using Variable Dose Analysis (VDA)
Housden, BE; Li, Z; Kelley, C; et al.Wang, Y; Hu, Y; Valvezan, AJ; Manning, BD; Perrimon, N
Date: 28 November 2017
Journal
Proceedings of the National Academy of Sciences
Publisher
National Academy of Sciences
Publisher DOI
Abstract
Synthetic sick or synthetic lethal (SS/L) screens are a powerful way to identify candidate drug targets to specifically kill tumor cells, but this approach generally suffers from low consistency between screens. We found that many SS/L interactions involve essential genes and are therefore detectable within a limited range of knockdown ...
Synthetic sick or synthetic lethal (SS/L) screens are a powerful way to identify candidate drug targets to specifically kill tumor cells, but this approach generally suffers from low consistency between screens. We found that many SS/L interactions involve essential genes and are therefore detectable within a limited range of knockdown efficiency. Such interactions are often missed by overly efficient RNAi reagents. We therefore developed an assay that measures viability over a range of knockdown efficiency within a cell population. This method, called Variable Dose Analysis (VDA), is highly sensitive to viability phenotypes and reproducibly detects SS/L interactions. We applied the VDA method to search for SS/L interactions with TSC1 and TSC2, the two tumor suppressors underlying tuberous sclerosis complex (TSC), and generated a SS/L network for TSC. Using this network, we identified four Food and Drug Administration-approved drugs that selectively affect viability of TSC-deficient cells, representing promising candidates for repurposing to treat TSC-related tumors.
Institute of Biomedical & Clinical Science
Collections of Former Colleges
Item views 0
Full item downloads 0